Compare Quant Healthcare Fund vs UTI Healthcare Fund
Risk | Very High | Very High |
Rating | - | 4.0 |
Min SIP Amount | ₹1000 | ₹500 |
Expense Ratio | 2.42 | 2.28 |
NAV | ₹14.12 | ₹270.41 |
Fund Started | 27 Jun 2023 | 01 Aug 2005 |
Fund Size | ₹362.34 Cr | ₹1101.63 Cr |
Exit Load | Exit load of 1%, if redeemed within 15 days. | Exit load of 1% if redeemed within 30 days. |
Risk
Very High
Very High
Rating
-
4.0
Min SIP Amount
₹1000
₹500
Expense Ratio
2.42
2.28
NAV
₹14.12
₹270.41
Fund Started
27 Jun 2023
01 Aug 2005
Fund Size
₹362.34 Cr
₹1101.63 Cr
Exit Load
Exit load of 1%, if redeemed within 15 days.
Exit load of 1% if redeemed within 30 days.
1 Year | -8.20% | -3.53% |
3 Year | - | 22.40% |
5 Year | - | 13.59% |
1 Year
-8.20%
-3.53%
3 Year
-
22.40%
5 Year
-
13.59%
Equity | 99.35% | 99.40% |
Cash | -5.39% | 0.59% |
Equity
99.35%
99.40%
Cash
-5.39%
0.59%
Top 10 Holdings |
|
|
Top 10 Holdings
Cipla Ltd. | 10.01% |
SMS Pharmaceuticals Ltd. | 9.58% |
Sequent Scientific Ltd. | 8.50% |
Zydus Wellness Ltd. | 8.05% |
Aster DM Healthcare Ltd. | 7.60% |
Aurobindo Pharma Ltd. | 7.09% |
Pfizer Ltd. | 6.60% |
Alivus Life Sciences Ltd | 6.23% |
Anthem Biosciences Ltd. | 6.00% |
Adani Enterprises Ltd. | 5.87% |
Sun Pharmaceutical Industries Ltd. | 9.37% |
Ajanta Pharma Ltd. | 7.16% |
Lupin Ltd. | 5.65% |
Glenmark Pharmaceuticals Ltd. | 4.06% |
Gland Pharma Ltd. | 3.60% |
Procter & Gamble Health Ltd. | 3.46% |
Dr. Reddy's Laboratories Ltd. | 3.46% |
Cipla Ltd. | 3.43% |
Alkem Laboratories Ltd. | 3.40% |
Apollo Hospitals Enterprise Ltd. | 3.39% |
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The scheme seeks to long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns. | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. |
Launch Date | 27 Jun 2023 | 01 Aug 2005 |
Description
The scheme seeks to long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
27 Jun 2023
01 Aug 2005